$798 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 22 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 30.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
QDEL | Sell | QUIDEL CORP | $316,080,000 | -19.8% | 1,759,421 | -2.0% | 39.61% | -23.7% |
BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $184,128,000 | +36.5% | 2,148,271 | +3.5% | 23.07% | +29.8% |
AWH | Sell | ASPIRA WOMENS HEALTH INC | $58,022,000 | +117.5% | 8,647,094 | -0.0% | 7.27% | +106.8% |
OPK | Sell | OPKO HEALTH INC | $52,027,000 | +5.6% | 13,171,273 | -1.4% | 6.52% | +0.4% |
PACB | PACIFIC BIOSCIENCES CALIF IN | $44,655,000 | +162.8% | 1,721,459 | 0.0% | 5.60% | +149.9% | |
AGEN | Sell | AGENUS INC | $37,691,000 | -28.3% | 11,852,372 | -9.8% | 4.72% | -31.8% |
AXDX | Sell | ACCELERATE DIAGNOSTICS INC | $28,851,000 | -33.9% | 3,806,139 | -7.0% | 3.62% | -37.1% |
BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $22,207,000 | +156.0% | 2,980,870 | +18.0% | 2.78% | +143.5% |
New | DERMTECH INC | $14,598,000 | – | 450,000 | +100.0% | 1.83% | – | |
ATRS | Buy | ANTARES PHARMA INC | $7,581,000 | +65.2% | 1,900,000 | +11.8% | 0.95% | +57.0% |
SLNO | SOLENO THERAPEUTICS INC | $7,084,000 | -23.1% | 3,670,384 | 0.0% | 0.89% | -26.9% | |
YMAB | Buy | Y-MABS THERAPEUTICS INC | $6,255,000 | +546.2% | 126,342 | +401.1% | 0.78% | +512.5% |
AMRN | Buy | AMARIN CORP PLCspons adr new | $5,050,000 | +18.1% | 1,032,786 | +1.7% | 0.63% | +12.4% |
BDSX | New | BIODESIX INC | $4,194,000 | – | 235,511 | +100.0% | 0.53% | – |
MOTS | MOTUS GI HLDGS INC | $3,609,000 | -3.0% | 3,806,666 | 0.0% | 0.45% | -7.8% | |
TBIO | New | TRANSLATE BIO INC | $1,843,000 | – | 100,000 | +100.0% | 0.23% | – |
QDEL | Sell | QUIDEL CORPcall | $1,085,000 | -83.7% | 119,700 | -47.5% | 0.14% | -84.5% |
BIIB | BIOGEN INC | $903,000 | -13.7% | 3,688 | 0.0% | 0.11% | -18.1% | |
CFRX | CONTRAFECT CORP | $846,000 | -4.4% | 167,587 | 0.0% | 0.11% | -9.4% | |
BIOL | BIOLASE INC | $725,000 | +51.7% | 1,739,100 | 0.0% | 0.09% | +44.4% | |
BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO Lcall | $400,000 | -5.4% | 100,000 | +46.8% | 0.05% | -10.7% |
WBA | New | WALGREENS BOOTS ALLIANCE INCcall | $203,000 | – | 200,400 | +100.0% | 0.02% | – |
AMRN | Exit | AMARIN CORP PLCcall | $0 | – | -305,300 | -100.0% | -0.00% | – |
AGEN | Exit | AGENUS INCcall | $0 | – | -105,200 | -100.0% | -0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
BIOGEN INC | 42 | Q3 2023 | 0.6% |
QUIDEL CORP | 36 | Q1 2022 | 52.5% |
AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
VERMILLION INC | 28 | Q1 2020 | 3.8% |
AGENUS INC | 25 | Q3 2023 | 9.8% |
TESARO INC | 23 | Q4 2018 | 27.8% |
ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.